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Abstract
Background: We have found that acetate supplementation significantly reduces neuroglia activation and
pro-inflammatory cytokine release in a rat model of neuroinflammation induced with lipopolysaccharide. To test if
the anti-inflammatory effect of acetate supplementation is specific to a TLR4-mediated injury, we measured markers
of neuroglia activation in rats subjected to B. burgdorferi-induced neuroborreliosis that is mediated in large part by
a TLR2-type mechanism.
Methods: In this study, rats were subjected to Lyme neuroborreliosis following an intravenous infusion of B.
burgdorferi (B31-MI-16). Acetate supplementation was induced using glyceryl triacetate (6g/kg) by oral gavage.
Immunohistochemistry, qPCR, and western blot analyses were used to measure bacterial invasion into the brain,
neuroglial activation, and brain and circulating levels of interleukin 1β. Statistical analysis was performed using
one-way analysis of variance (ANOVA) followed by a Tukey’s post hoc tests or using a Student’s t test assuming
unequal variances when appropriate.
Results: We found that acetate supplementation significantly reduced microglia activation by 2-fold as determined
by immunohistochemical and western blot analysis. Further, acetate supplementation also reduced the expression
of the pro-inflammatory cytokine IL-1β by 2-fold as compared to controls. On the other hand, the inoculation of
rats with B. burgdorferi had no effect on astroglial activation as determined by immunocytochemistry and western
blot analysis despite significant increases in circulation levels of antigen toward B. burgdorferi and presence of the
bacteria in the central nervous system.
Conclusions: These results suggest that microglial activation is an essential component to neuroborreliosis and
that acetate supplementation may be an effective treatment to reduce injury phenotype and possibly injury
progression in Lyme neuroborreliosis.
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Background
Lyme disease, caused by the spirochete Borrelia burgdor-
feri, is an National Institue of Allergy and Infectious Dis-
eases/ National Institutes of Health Group I priority
emerging/re-emerging infectious disease and the most
frequently reported arthropod-borne disease of humans
in the United States [1]. B. burgdorferi can infect immune-
competent humans and other vertebrates for extensive
periods of time, even for the host’s lifetime [2-4]. The
Lyme disease spirochete is an extracellular organism
with an affinity for the central nervous system and
invades via hematogenous spread [5] and can be isolated
from cerebrospinal fluid (CSF) as early as 18 days after
the bite from an infected tick [6]. Lyme neuroborreliosis,
which occurs in 10 to 15% of untreated patients [7],
results in meningitis, headache and facial nerve palsy
[5]. B. burgdorferi adheres to primary neural cells from
mice and rats, as well as glial cell lines, resulting in dir-
ect cytotoxicity, increasing brain levels of activated CD8
T cells and B cells [5-7]. Since B. burgdorferi does not
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produce exotoxins, neurological damage is most likely a
result of the host’s own inflammatory response, in large
part by a TLR-2-mediated cellular recognition [8] that
increases levels of pro-inflammatory cytokine IL-1β, IL-
6, IL-8, TNF-α, and CXCL13 in the CSF [9].
Dietary acetate is a potentially effective therapy for the
treatment of Canavan disease [10] and reduces neuroin-
flammatory phenotype in rats subjected to neuroinflam-
mation [11]. In brain, acetate is converted to acetyl
coenzyme A (acetyl-CoA) through the combined action
of nuclear acetyl-CoA synthetase 1 [12] and mitochon-
drial acetyl-CoA synthetase 2 [13]. When acetate is sup-
plied by a single oral dose of glyceryl triacetate (GTA),
brain acetyl-CoA levels increase by 2.2-fold, it reduces
neuroglia activation by 40 to 50% [11], increases histone
acetylation [14], and is anti-inflammatory with regard to
reducing IL-1β in a rat model of neuroinflammation [15].
Further, in cultured microglia, acetate treatment shifts
the release of cytokines to a more anti-inflammatory
state through mechanisms that involve both histone and
non-histone protein acetylation [16]. These data suggest
that altering acetyl-CoA metabolism may be active at
modulating the neural immune response. In this regard,
acetyl-CoA is a widely active precursor in numerous bio-
logical processes that is central to mitochondrial energy
supply, fatty acid synthesis, and lipid metabolism [17]. In
addition, acetyl-CoA is utilized as a substrate for protein
acetylation which, when it occurs on nuclear histones,
leads to chromatin architectural changes and changes in
gene expression [18]. Therapeutically, increases in the
histone acetylation are implicated as being protective in
animal models of cerebral ischemia [19], neuroinflamma-
tion [11], and amyotrophic lateral sclerosis [20]. An in-
crease in histone acetylation also reduces microglial
activation in traumatic brain injury [21], and restores
impaired learning and memory in neurodegenerative
diseases [22].
The focus of this study was to evaluate acetate supple-
mentation as a therapeutic strategy to reduce neuroin-
flammation in rats subjected to Lyme neuroborreliosis.
Because an increase in acetyl-CoA metabolism is driven
by alterations in intracellular acetate utilization, we be-
lieve that this therapy can be used to effectively attenu-
ate the TLR2-induced neural immune response as found
in Lyme neuroborreliosis. To test this hypothesis, we mea-
sured the effectiveness of acetate supplementation to at-
tenuate brain microglial and astroglial activation and
decrease brain levels of the pro-inflammatory cytokine
IL-1β in rats inoculated with B. burgdorferi.
Methods
Reagents
Glyceryl triacetate, 2-mercaptoethanol, buffers, fixative
solutions, a Cy3-labeled monoclonal anti-glial fibrillary
acidic protein (GFAP) antibody (C9205) were purchased
from Sigma-Aldrich (St. Louis, MO, USA), and Texas
Red™-labeled tomato lectin antibody (TL-1176), normal
horse serum, normal goat serum, and Vectashield™ were
obtainedfromVectorLaboratories (Burlingame,CA,USA).
An antibody recognizing integrin alpha M chain (CD11b),
the rat homolog of the human C3bi complement recep-
tor, a non-labeled GFAP antibody, an alpha tubulin anti-
body 3,30-diaminobenzidine tetrahydrochloride, and a
biotinylated goat anti-rabbit immunoglobulin G (IgG)
were purchased from Millipore (Billerica, MA, USA) and
a fluorescein-conjugated anti-B. burgdorferi polyclonal
antibody and isotype control antibody was purchased from
KPL (Gaithersburg, MD, USA). Absolute ethanol was
from Pharmco (Brookfield, CT, USA) and all other
reagents unless noted otherwise were purchased from
EMD Chemicals (Gibbstown, NJ, USA).
Bacterial culture
Virulent B. burgdorferi strain B31-MI-16 [23,24] was
grown at 34°C to cell densities of approximately 1 × 107mL
in modified Barbour-Stoenner-Kelly II (BSK-II) medium
[25]. Bacteria were pelleted by centrifugation (6000 × g,
10 min) and washed three times with phosphate-buffered
saline (PBS; 9.6 mM NaH2PO4, 0.73 mM KH2PO4, 137
mM NaCl, 2.7 mM KCl, pH 7.4). Bacteria were enumer-
ated by dark field microscopy using a Petroff-Hausser
chamber (Hausser Scientific, Horsham, PA, USA).
Animal studies
This study was conducted in accordance with the NIH
Guidelines for the Care and Use of Laboratory Animals
under an approved by the University of North Dakota
Institutional Animal Care and Use committee using male
Sprague–Dawley rats (Charles River, Wilmington, MA,
USA). All rats were acclimated in our facility for at least
seven days prior to inclusion in the study and maintained
on a constant 12 h light cycle. Rats were fed a standard
2018 Teklad Global 18% protein rodent diet (Harlan,
Madison, WI, USA) ab libidum. Infected rats were inocu-
lated with B. burgdorferi bacteria via an intravenous tail
vein injection at a dose of 5 × 105 bacteria per rat. Fol-
lowing inoculation, rats were treated daily with either
GTA or water (6 g/kg body weight) by oral gavage. At
28 days the rats were anesthetized with an intravenous
injection of pentobarbital (50 mg/kg) and those used for
western blot analysis were subjected to decapitation,
brains were removed, flash frozen in liquid nitrogen, and
stored at −80°C until use. Rats used for immunohisto-
chemistry were euthanized by cardiac perfusion with
0.9% saline containing 1000 units/L sodium heparin
(Baxter, Deerfield, IL, USA) followed by a mixture of 4%
paraformaldehyde and 2% glutaraldehyde in 0.1 M phos-
phate buffer. Whole brains were removed then post-
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fixed in the same paraformaldehyde mixture for 48 h at
4°C. The fixed brains were transferred to 0.1 M PBS, pH
7.4 and stored at 4°C.
Enzyme-linked immunosorbent assay (ELISA)
Rat blood was drawn from the tail artery and collected
in heparin-coated tubes. Blood samples were centrifuged
(6,000 × g) to remove red blood cells and the serum was
stored at −20°C. To measure rat IgM against B. burgdor-
feri, 96-well plates were coated overnight with 10 μg/mL
B. burgdorferi lysate (mid-log phase B. burgdorferi B31-
MI-16) in carbonate coating buffer (0.32g Na2CO3,
0.586g NaHCO3 per 200 mL, pH 9.6) at 4°C. Protein
concentration was determined using a bicinchroninic
acid assay (Pierce, Rockford, IL, USA). Room temper-
ature plates were washed once with PBS containing
0.05% Tween 20 (by Vol., PBS-T). Wells were blocked
for 2 h at room temperature with PBS containing 2% bo-
vine serum albumin (BSA) then washed three times with
PBS-T. At the time of the assay a 1:100 dilution of
serum in PBS was placed on the plate and incubated for
2 h at 37°C. Wells were washed three times with PBS-T
then incubated for 1 h at room temperature with horse-
radish peroxidase-conjugated goat antiserum against rat
IgM diluted to 1:5000 in PBS, (AbD Serotec, Raleigh,
NC, USA). Color development was performed using a
tetramethylbenzidine substrate (TMB; Thermo Scien-
tific, Rockford, IL, USA) for 15 min, and stopped with
the addition of 2 N sulfuric acid. Circulating IL-1β levels
were measured using ELISA according to the manufac-
turer’s instructions (catalog number RLB00, R&D Sys-
tems, Minneapolis, MN, USA). Plates were incubated for
2 h at room temperature, washed using aspiration, fol-
lowed by the addition of an antibody conjugate then in-
cubation for 2 h at room temperature. The antibody
conjugate was washed from the plates and IL-1β was
detected by adding a chromogenic substrate. Absorbance
from both assays was measured at 450 nm using a Bio-
Tek Epoch plate reader with KC4 software (BioTek,
Winooski, VT, USA).
Analysis of B. burgdorferi recA DNA levels
Total DNA was extracted from frozen tissue samples
using a DNeasy kit (Qiagen, Valencia, CA, USA) as
described in the manufacturer’s instructions. A quantita-
tive polymerase chain reaction (qPCR) was performed
by using a Bio-Rad MyiQ2 thermal cycler (Bio-Rad,
Hercules, CA, USA) where each run included a sample
that lacked template to measure DNA contamination.
Oligonucleotide primers used for amplification were B.
burgdorferi recA nTM17F 50GTGGATCTATTGTATTAGA
TGAGGCTCTCG30; B. burgdorferi recA nTM17R 50
GCCAAAGTTCTGCAACATTAACACCTAAAG30 [26];
and RT2 qPCR primer set for rat cyclophilin A (Ppia)
(catalog number PPR06504A, SABiosciences, Frederick,
MD, USA). The qPCR was performed in 40 cycles following
an initial 10 min denaturation at 95°C. Each cycle consisted
of a 1 min annealing step performed at 55 or 60°C for B.
burgdorferi or rat genomic DNA, respectively, followed by
a 15 sec melting interval at 95°C. Product melting curves
were generated at the end of the reaction using a stepped
temperature gradient of 0.5°C × 10 sec starting at 60°C. A
10-fold serial dilution of B. burgdorferi (B31-MI-16) gen-
omic DNA or rat genomic DNA was included in every
assay for each primer set. This enabled the generation of
standard curves from which the amount of DNA present in
each sample could be calculated using the Bio-Rad MyiQ2
software. The same software package was also used for
melting-curve analyses. To verify amplicon sizes and puri-
ties, all products were separated by agarose gel electrophor-
esis, and DNA was visualized with ethidium bromide. B.
burgdorferi recA copies were calculated relative to the aver-
age triplicate value for the rat cylophilin A housekeeping
gene from the same DNA preparation and reported as the
averaged values obtained from triplicate runs of each
sample.
Brain protein extraction
Rat brains were removed from storage at −80°C and
placed on ice. Each brain was then dissected at the mid-
dle carotid artery, and the anterior portion was placed in
a scintillation tube with 3 mL of ice-cold extraction buf-
fer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 1
mM EGTA, 1 mM sodium orthovanadate, 5 mM ZnCl2,
100 mM NaF, 1 mM PMSF, 0.1% Igepal CA-630, and
one Complete™, EDTA-free tablet (Catalog number
05056489001, Roche Applied Science, Indianapolis, IN,
USA) per 50 mL [27]. The solution containing the sam-
ple was then allowed to sit on ice for 10 min then homo-
genized using probe sonication until no solid was
evident. Once homogenized, samples were centrifuged
(4,500 × g) at 4°C for 20 min [28]. The cytosolic extract
was aliquoted into 200 μL volumes and stored at −80°C.
Western blot analysis
Samples were allowed to thaw on ice then prepared for
electrophoresis in Laemmli sample buffer containing 5%
2-mercaptoethanol. Electrophoresis was performed on
50 μg of protein using a 15% Tris–HCl gel at 100 volts
for 135 min. The protein was transferred onto a 0.45 μm
nitrocellulose membrane at 100 volts for 90 min on ice.
Primary antibodies (1: 500 dilution) were prepared in 20
mM Tris buffer, pH 7.4 containing 150 mMNaCl, 0.05 %
Tween 20 (TTBS), and 5% non-fat dried milk. The nitro-
cellulose membranes were incubated with primary anti-
body overnight at 4°C then conjugated with horseradish
peroxidase-linked secondary antibody (1:10,000 dilution)
for 90 min at room temperature. Protein bands were
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detected using SuperSignal™ West Femto Chemilumines-
cent Substrate (Pierce, Rockford, IL, USA) and analyzed in
a UVP Bioimaging System (Upland, CA, USA) using Lab-
Works™ imaging software (version 4.5). All western blot
data is expressed as the ratio of the optical density of the
target antibody normalized to the optical density α-tubulin
and reported as the percent of control. Protein concentra-
tions were measured using the Bradford assay [29].
Fixation, sectioning, and antigen retrieval
Post-fixed rat brains were equilibrated at 4°C in a 0.1 M
phosphate buffer (pH 7.2) solution containing 20% sucrose.
Sucrose-impregnated brains were frozen in isopentane (Alfa
Aesar, Ward Hill, MA, USA) cooled to −50°C on dry ice,
then mounted onto cryostat pedestals with M-1 embedding
matrix (Lipshaw, Pittsburgh, PA, USA). A cryostat (IEC,
Needham Hts., MA, USA) was used to cut 20 μm serial cor-
onal brain sections, which were mounted on gelatin-coated
glass slides. Themounted sections were stored in slide cases
at −80°C until use. The sections were rehydrated in 0.1 M
Tris-buffered saline, pH 7.6 (TBS) prior to antigen retrieval
to enhance antibody-binding efficiency as described [30].
Immunohistochemistry
Immunohistochemistry was performed using antibody
dilutions of 1:1000 for the Texas Red™-labeled tomato
lectin, 1:400 for the Cy3-labeled GFAP, and 1:400 for
the non-labeled GFAP. White field immunohistochem-
istry using the non-labeled GFAP antibody with the bio-
tinylated secondary was performed as described [11].
To measure brain bacterial spirochetes, a dilution of
1:5000 was used for the fluorescein-conjugated anti-B.
burgdorferi antibody and to rule out non-specific bind-
ing a fluorescein-conjugated isotype control antibody
was used at a dilution of 1:5000. Following antigen re-
trieval, samples were washed with three 10 min washes
in 0.1 M PBS, pH 7.4 + 0.1% Triton™ X-100 (EMD Che-
micals, Gibbstown, NJ, USA) (PBS-T buffer). The sec-
tions were then incubated for 1 h in blocking solution
containing 1% BSA, 0.25% Triton™ X-100, 3% horse
serum, and 10% goat serum in PBS then with primary
antibody for 24 h at 4°C in hydration chambers. After in-
cubation the sections were washed with PBS, dehydrated
with increasing concentrations of ethanol/water solu-
tions (70, 95, and 100% ethanol by Vol.), then equili-
brated in xylene/ethanol (1:1, by Vol.) followed by 100%
xylene. The dehydrated samples were covered with slips
using Vectashield™. Confocal images were collected on
a Zeiss LSM 510 META confocal microscope (Carl Zeiss
MicroImaging, Thornwood, NY, USA) (Zeiss AIM soft-
ware version 4.2 SP1) using a 488 nm Argon laser line, a
543 nm HeNe laser line and appropriate filters for visu-
alizing the fluorophores.
Statistical analysis
A one-way analysis of variance (ANOVA) followed by a
Tukey’s post hoc and assumption tests were used to
calculate statistical differences using GraphPad InStat
statistical software (version 3.10, GraphPad Software,
San Diego, CA, USA). The statistical analyses of brain
qPCR data were performed using Student’s t test and
assuming unequal variances. All results are expressed as
means ± SD with significance set at P ≤0.05, unless
noted otherwise. The sample size of all serum, brain
qPCR, and immunohistochemical analyzes were set at
six representing sampling from six different rats. West-
ern blot analysis was performed on brain extracts from
seven control rats, six rats inoculated with B. burgdorferi
that were treated with water and five rats inoculated with
B. burgdorferi and treated with GTA.
Results
Induction of neuroborreliosis in the rat
To determine the presence of bacteria in the brain and
to gauge the extent by which neuroborreliosis is in-
duced in the rat, we inoculated a cohort of animals with
B. burgdorferi (5 x 105 cells per rat). At varying times,
post-inoculation experiments measuring serum IgM re-
activity toward the bacteria, B. burgdorferi recA copy
number, and immunohistochemistry were performed to
identify the presence of the spirochete. These results
show that serum B. burgdorferi IgM levels at 28 days
after the inoculation were 3-fold higher when compared
to control naive rats (Figure 1A). These data suggest that
the inoculation strategy was effective at increasing cir-
culating levels of B. burgdorferi in the blood stream. To
assess the presence and the extent by which the bacteria
invade the brain we measured recA copy number using
qPCR focusing on the recA gene transcript, a standard
marker for the presence of B. burgdorferi in which a sin-
gle copy of recA is present per spirochete. These experi-
ments showed that six out of seven of the infected rats
had detectable levels of B. burgdorferi in the brain. The
content of recA transcript was 14-fold above that found
in the naïve rat at 28 days (Figure 1B) and increased 2-
fold between days 7 and 28 post-infection (data not
shown). To further support the presence of bacteria in
the brain, an immunohistochemical analysis was per-
formed using a fluorescently labeled antibody toward B.
burgdorferi. Immunoreactivity toward the B burgdorferi
antibody was found in all rats inoculated with bacterium
(six out of six) showing reactivity in all brain regions ana-
lyzed (cortex, hippocampus, and striatum). No immu-
noreactivity was found in control rat brains (six out of
six) and no immunoreactivity was found in inoculated
rats screened with a fluorescently labeled isotype con-
trol antibody (six out of six). When serial fluorescent
images from inoculated rats screened with B. burgdorferi
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antibody were reconstructed into Z-axis stacks, they
showed the presence of prototypical B. burgdorferi spiro-
chetes (Figure 1C). These data suggest that following an
initial inoculation with B. burgdorferi at a concentration
of 5 × 105 cells per rat, a significant number of bacteria
enter the rat brain and possibly continue to reproduce
and induce neuroborreliosis.
Acetate supplementation and neuroglia reactivity in rat
subjected to B. burgdorferi
In an effort to determine the therapeutic efficacy of acet-
ate supplementation on reducing neuroglia reactivity the
content of brain CD11b, a marker of microglia activa-
tion, and GFAP, a marker of astrocyte reactivity, were
performed using western blot analysis on naïve rats and
rats subjected to B. burgdorferi. To confirm the western
blot analysis, immunohistochemical analysis showing
morphological changes in lectin-positive microglia and
GFAP-positive astrocytes were performed. These experi-
ments show that CD11b protein levels were increased 4-
fold in rats subjected to a B. burgdorferi infection and
treated with water as compared to control naïve rats
(Figures 2A and 2B). Conversely, rats that were sub-
jected to B. burgdorferi and treated prophylactically with
GTA demonstrated a significant reduction in the levels
of CD11b to control levels. Immunohistochemical ana-
lysis of tomato lectin-positive microglia showed that
microglia in water-treated rats display a characteristic
ramified structure with an increase cytoplasmic and
dendrite volume (Figure 2C). In rats treated prophylac-
tically with GTA, microglia maintain a non-stimulated
morphology (Figure 2D) consistent with the western blot
analysis. On the other hand, infection did not alter the
content of GFAP, the morphology of GFAP-positive
astrocytes (Figure 3, C and E), nor did it alter the distri-
bution of GFAP-positive astrocytes (Figure 3, D and F)
in the brains of rats treated with either water or GTA
(Figure 3 A-D). These data suggest that following infec-
tion, one of the primary cells in brain involved in the in-
duction of neuroborreliosis may be the microglia and
that B. burgdorferi induces, at least in part, the innate
immune response in brain. Further, these data suggest
that treatment of infected rats with prophylactic GTA
can reverse the induction of microglia similar to that
found in rats subjected to lipopolysaccharide (LPS)-
induced neuroinflammation [11,15].
Acetate and pro-inflammatory IL-1β levels in rats
subjected to B. burgdorferi
We have demonstrated that one of the functional out-
comes of acetate supplementation in attenuating LPS-
induced neuroinflammation is a reduction in the expres-
sion of the pro-inflammatory cytokine IL-1β [15]. To de-
termine the effect that acetate supplementation has on
IL-1β in rats subjected to B. burgdorferi, we measured
serum changes in this cytokine between the date of in-
oculation and 28 days and measured brain levels at 28
days. In these experiments, we found that circulating
Figure 1 Induction of neuroborreliosis following a single inoculation with B. burgdorferi. Serum levels of IgM towards B. burgdorferi were
measured at 28 days post-inoculation in naïve and infected rats, panel (A). recA copy number was measured to determine the magnitude of
brain infection in naïve and infected rats, panel (B) and immunohistochemistry was performed to identify the presence of B. burgdorferi in an
infected rat brain at 28 days post-inoculation, panel (C). Values represent the means ± SD of serum immunoreactivity, or brain copy number with
a sample size of six representing samples from six different rats per group. The asterisk (*) represents a significant difference (P ≤0.05) comparing
infected to naïve rats using an unpaired t test (GraphPad InStat, version 3.10).
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Figure 3 The effect of acetate supplementation on reactive astrogliosis in rats subjected to neuroborreliosis. Panel (A) shows a
representative image of the western blot analysis measuring glial fibrillary acidic protein (GFAP) immunoreactivity, a marker of astroglial activation,
and panel (B) is the composite measure of the western blot analysis. Panels (C) and (E) show representative high-magnification images of
Cy3-labeled GFAP-positive astroglia in infected rats treated with either water or glyceryl triacetate (GTA), respectively and panels (D) and (F) show
low-magnification images of GFAP-positive astrocytes in infected rats treated with either water or GTA, respectively. The values in panel B
represent the means ± SD expressed in units of fold-increase over naïve rats with a sample size of seven (naïve), six (infected + water), and five
(infected +GTA).
Figure 2 The effect of acetate supplementation on microglia reactivity in rats subjected to neuroborreliosis. Panel (A) shows a
representative image of the western blot analysis measuring integrin alpha M chain (CD11b) and immunoreactivity, a surrogate marker of
microglia activation, and panel (B) represents the composite measure of the western blot analysis. Panel (C) and (D) show representative images
of tomato lectin-positive microglia (Arrows) in infected rats treated with either water or glyceryl triacetate (GTA), respectively. The values in panel
B represent the means ± SD expressed in units of fold-increase over naïve rats where ‘a’ represents a significant increase compared to naïve rats
and ‘b’ represents a significant difference comparing infected rats treated with GTA to infected rats treated with water (n = 6, P ≤0.05). The
reticule in panels C and D represent a length of 10 μm.
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levels of IL-1β did not differ between infected rats trea-
ted with either water or GTA at any of the time points
measured (Figure 4A). The serum levels of IL-1β in
infected rats treated with water, however, were signifi-
cantly higher at days 3 and 6 compared to day 28 post-
infection suggesting that infection does alter circulating
levels of this cytokine at least transiently. Serum con-
centrations on day 28 did not differ between naïve rats
and infected rats treated with either water or GTA
(Figure 4B). As expected, treatment with GTA signifi-
cantly reduced brain levels of IL-1β protein by 30%
below that found in either naïve or infected rats treated
with water (Figure 4C and D). Because circulating levels
of IL-1β were not significantly different on day 28 cou-
pled to the reductions in activated microglia suggests
that the decrease in IL-1β levels in brain are the result
of a reduction in microglia reactivity.
Discussion
As a proof-of-concept study we measured the effec-
tiveness of acetate supplementation to reverse pro-
inflammatory events in the brains of rats subjected to a
B. burgdorferi infection. In these experiments, we found
that the spirochete invaded the rat brain and induced
microglial activation. Further, acetate supplementation
was effective at reversing brain microglia activation and
reduced IL-1β levels, suggesting that treatment may re-
duce the pathologic sequelae in brain associated with
Lyme neuroborreliosis.
Ninety percent of all vector-borne diseases in the Uni-
tes States can be attributed to Lyme disease. Because of
its importance as an emerging/infectious disease, devel-
oping rodent models of Lyme disease is crucial to begin
to understand how neuroborreliosis develops, and ne-
cessary to develop potential therapeutics to alleviate its
long-term debilitating effects on the patient’s health [3,4].
Currently, the primary animal model used to study Lyme
neuroborreliosis is the primate rhesus macaque model, in
which neuroborreliosis is induced by the intracerebral
ventricular injection of B. burgdorferi. In this model,
there is persistent neuroglial activation, production of
high levels of pro-inflammatory cytokine, and neuronal
and glial apoptosis [9]. Consistent with these findings we
found that following inoculation, rat brain microglia were
significantly activated compared to control rats. How-
ever, we did not find activation of astrocytes in brains of
infected rats as determined by immunohistochemical
and western blot analysis. We believe that the lack of re-
active astrogliosis found in this study is due in part to
our mode of inoculation and the quantity of bacteria
introduced. The primate model uses an intrathecal injec-
tion into the cisterna magna with 1 × 108 spirochetes
Figure 4 The effect of acetate supplementation on B. burgdorferi-induced increases in brain IL-1β. Panel (A) represents the time-
dependent changes in serum IL-1β between the day of inoculation (day 0) and 28 days post-infection showing infected rats treated with either
water or glyceryl triacetate (GTA). Panel (B) represents serum IL-1β levels at 28 days post-infection in naïve and infected rats treated with either
water or GTA. Panel (C) shows a representative image of the IL-1β and α tubulin western blots and panel (D) represents the composite analysis of
the western blot analysis brain IL-1β in naïve and infected rats treated with either water or GTA. Values represent the means ± SD with a sample
size of seven, six and five per group, respectively. The asterisk (*) represents a significant difference comparing GTA-treated rats to
water-treated rats.
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[31]. Here, rats were injected with a loading dose of 1 ×
105 spirochete given intravenously, which resulted in a
much lower challenge. The specifics concerning the de-
velopment of Lyme neuroborreliosis are unclear, but the
role that microglia have in the initiation and progression
of this disease is less ambiguous. Microglia are directly
activated when exposed to B. burgdorferi and involved in
neuronal-glia and glial communication [32]. While mul-
tiple cell types in the brain express MHC, in studies
using minocycline (a suppressor of microglia) microglia
activation was essential to induce stress-induced ERK1/2
neuroimmune modulation [33]. Further, the rapid in-
crease in the expression of IL-1 receptor on microglia in
response to endotoxin and vascular occlusion support
the role of microglia as being a primary initiator of the
neuroimmune response [34,35]. Based on this data, we
believe an initiating event associated with Lyme neuro-
borreliosis is the activation of resident microglia. The in-
crease in the number of bacteria found in the brain
between 7 and 28 days further supports this premise, al-
though experiments focused on a longer duration will be
necessary to determine if microglia activation will stimu-
late reactive astrogliosis in this model.
At the onset of these studies we proposed that acetate
supplementation, through a mechanism involving short
chain acetyl-CoA metabolism, would attenuate neuroin-
flammation induced by B. burgdorferi similar to that
seen in rats subjected to neuroinflammation [11]. Energy
supplementation as a therapeutic strategy to treat neu-
rodegenerative disorders is well appreciated [36-38] and
with regard to acetate supplementation works by bol-
stering acetyl-CoA levels via acetyl-CoA synthetases
[12,13]. An increase in acetyl-CoA can stimulate brain
energy metabolism, increase lipid deposition, and alter
protein acetylation. Mitochondrial dysfunction and neu-
roinflammation are thought to synergistically activate a
cycle of deleterious events leading to neuronal death
[39]. Microglia, thought to be primary mediators of neu-
roinflammation, release potentially harmful factors, in-
cluding reactive oxygen species and pro-inflammatory
cytokines that can damage mitochondria [40]. It is known
that neural mechanisms are involved in inflammatory
responses in brain [41] and that the outcome of certain
neurodegenerative disorders is influenced by the balance
between pro- and anti-inflammatory mediators [42]. The
results showing the ability of acetate to completely atten-
uate microglia activation and IL-1β level further supports
these findings. Mitochondrial disruption in microglia cell
culture stimulated with LPS disrupts the balance between
pro- and anti-inflammatory cytokine production, suggest-
ing that mitochondrial integrity is necessary to support
injury resolution [43]. In this regard, acetate treatment in
cultured microglia increases the transcription of the anti-
inflammatory cytokines transforming growth factor-beta
1 (TGF-β1) and IL-4, suggesting that acetate-induced
histone modulation may influence more strongly the ex-
pression of anti-inflammatory cytokines [16]. However,
acetate also reduces the expression of pro-inflammatory
cytokines Il-1β and TNFα in microglia without altering
RNA. Thus while an increase in the expression of anti-
inflammatory cytokines may have a role in reducing
microglial activation, other alterations in inflammatory
signaling that are influenced by protein acetylation are
also likely involved. Furthermore, primary mitochondrial
dysfunction resulting from exposure to neurotoxins in-
duces microglial activation [39] of which can trigger neu-
rodegeneration [40,44]. Taken together, these data provide
a reasonable rationale to suggest that stimulating acetyl-
CoA metabolism in rats subjected to B. burgdorferi may
influence neuroglial communication and possibly disrupt
the progression of Lyme neuroborreliosis.
Conclusions
Rats inoculated with B. burgdorferi demonstrate charac-
teristics of microglia activation that is reversed to con-
trol levels when treated prophylactically with acetate
supplementation. In this regard, acetate supplementation
was able to completely resolve morphological changes in
resident microglia, attenuated CD11b to control levels,
and reduced brain-derived IL-1β levels as compared to
rats that were inoculated with B. burgdorferi. Interest-
ingly, infected rats did not demonstrate reactive astro-
gliosis as characteristic in primate models of Lyme
neuroborreliosis. This, we believe, is a result of a signifi-
cantly lower bacterial challenge in our study as com-
pared to primate models, where considerably more
bacteria are directly introduced into the brain. Further,
these results support the premise that acetate supple-
mentation is effective at reducing TLR2-mediated neu-
roinflammation that may be attributed to stimulating
brain energy supplementation or a disruption ofmicroglia-
derived pro-inflammatory gene expression.
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